Cost-effectiveness of novel treatment of hepatitis C virus in Lebanese patients
Background Limited data is available on Hepatitis C disease prevalence, treatment initiation and its cost-effectiveness in Lebanon and the whole Middle East. Objective The aim of the study is to assess whether initiation of novel Direct Acting Antiviral agents (DAAs) at early stage of hepatitis C is...
Saved in:
| Main Author: | Nasser, Soumana C. (author) |
|---|---|
| Other Authors: | Mansour, Hanine (author), Abi Nader, Tatiana (author), Metni, Mirna (author) |
| Format: | article |
| Published: |
2018
|
| Online Access: | http://hdl.handle.net/10725/11501 https://doi.org/10.1007/s11096-018-0628-6 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://link.springer.com/article/10.1007/s11096-018-0628-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of hepatitis C virus isolate genotypes from chronically infected Lebanese patients
by: Mokhbat, J.
Published: (2003) -
Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections
by: Houssein H Ayoub (17704359)
Published: (2019) -
Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen
by: Mokhbat, J.
Published: (2008) -
Characterization of the hepatitis C virus epidemic in Pakistan
by: Sarwat Mahmud (4557208)
Published: (2019) -
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016
by: Mokhbat, Jacques
Published: (2018)